This is an outdated version published on 2022-09-28. Read the most recent version.

Working at a Cancer Research Laboratory as a Medical Student: Experience of an Indian Student Studying Medicine in Russia

Authors

DOI:

https://doi.org/10.5195/ijms.2022.1424

Keywords:

Medical Student, Russia, Biomedical Research

Abstract

Medical education is incomplete without any experience in medical research. In Russia, many international students study medicine, and some of them indulge in research along with their teachers and supervisors in different fields of medicine. Being one of such students, I narrated my experience of working at a cancer research laboratory in a Russian university and discussed the opportunities and difficulties that an international medical student might face while studying medicine and doing research simultaneously.

Metrics

Metrics Loading ...

References

Students’ science society named after I.A. Studentsova [Internet]. cited [2022 May 6]. Available from: https://sno.kazangmu.ru/en/

Boichuk S, Galembikova A, Dunaev P, Micheeva E, Valeeva E, Novikova M, et al. Targeting of FGF-Signaling Re-Sensitizes Gastrointestinal Stromal Tumors (GIST) to Imatinib In Vitro and In Vivo. Vol. 23, Molecules . 2018. DOI: https://doi.org/10.3390/molecules23102643

Boichuk S, Galembikova A, Dunaev P, Nurgatina I, Bikinieva F, Mani S, et al. Inhibition of FGFR-signaling pathway modulates sensitivity of gastrointestinal stromal tumors to imatinib. In: 12th Annual Meeting of the Korean Society of Medical Oncology & 2019 International Conference. Seoul, Korea: Korean Society of Medical Oncology; 2019. p. 97.

Boichuk S, Dunaev P, Galembikova A, Bikinieva F, Nurgatina I, Mani S, et al. Inhibition of FGFR2-signaling sensitizes imatinib resistant gastrointestinal stromal tumor to DNA-topoisomerase II inhibitor by attenuating homology mediated DNA repair. In: 2nd UK-Russia Young Medics Conference. Cambridge, UK: UK-Russia Young Medics Association; 2020. p. 24–5.

Mani S, Bikinieva F. GIST 430: A gastrointestinal stromal tumour cell line resistant to Imatinib-BGJ398 double targeted treatment. In: VII International Youth Scientific Medical Forum “White flowers.” Kazan, RU: Kazan State Medical University; 2020. p. 517.

Mani S, Pramanik N, Rao D, Sharma S, Akhmetov T. The Negative Correlation of Spice Intake and Colorectal Cancer: A Statistical Analysis of Global Health Databases. Int J Med Stud. 2020;8(3):238–44. DOI: https://doi.org/10.5195/ijms.2020.693

Boichuk S, Dunaev P, Mustafin I, Mani S, Syuzov K, Valeeva E, et al. Infigratinib (BGJ 398), a Pan-FGFR Inhibitor, Targets P-Glycoprotein and Increases Chemotherapeutic-Induced Mortality of Multidrug-Resistant Tumor Cells. Biomedicines. 2022;10(3):601. DOI: https://doi.org/10.3390/biomedicines10030601

Downloads

Published

2022-05-16 — Updated on 2022-09-28

Versions

How to Cite

Mani, S. (2022). Working at a Cancer Research Laboratory as a Medical Student: Experience of an Indian Student Studying Medicine in Russia. International Journal of Medical Students, 10(3), 321–323. https://doi.org/10.5195/ijms.2022.1424

Issue

Vol. 10 No. 3 (2022)

Section

Experience

Categories

License

Copyright (c) 2022 Shinjit Mani

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

  1. The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
  2. Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
  3. The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
    1. Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
    2. The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
    3. Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
    4. Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
    5. The Author represents and warrants that:
      1. the Work is the Author’s original work;
      2. the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
      3. the Work is not pending review or under consideration by another publisher;
      4. the Work has not previously been published;
      5. the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
      6. the Work contains no libel, invasion of privacy, or other unlawful matter.
    6. The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.

Enforcement of copyright

The IJMS takes the protection of copyright very seriously.

If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.

If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to contact@ijms.org

 

Infringing material

If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to contact@ijms.org